Skip to main content
OpenTrials

Clinical trial condition

Plaque, Amyloid

Explore clinical trials studying Plaque, Amyloid. Study availability and eligibility vary by location and protocol.

214 public trials 22 recruiting studies
Refine in advanced search Browse all conditions

Plaque, Amyloid trial results

Completed

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

NCT02474069

Conditions
Moderate to Severe Plaque-type Psoriasis, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, +6 more
Locations
  • Novartis Investigative Site Bad Bentheim, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
View all 89 locations
View Trial Details
Completed

Plaque Psoriasis Efficacy and Safety With Secukinumab

NCT02409667

Conditions
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +5 more
Locations
  • Novartis Investigative Site Innsbruck, Austria
  • Novartis Investigative Site Linz, Austria
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vienna, Austria
View all 200 locations
View Trial Details
Completed

Study to Evaluate Psoriasis Severity and Its Psychosocial Impact Using the Simplified Psoriasis Index (SPI), as Well as Long-term Safety, Tolerability and Efficacy of Secukinumab Administered Subcutaneously in Patients With Moderate to Severe Psoriasis

NCT02595970

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +10 more
Locations
  • Novartis Investigative Site Le Mans, Cedex 09, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Toulon, Val De Marne, France
  • Novartis Investigative Site Amiens, France
View all 17 locations
View Trial Details
Completed

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

NCT01241591

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +27 more
Locations
  • Centro de Investigaciones Dermatologicas Buenos Aires, C1114aap, Argentina
  • Centro de Investigaciones Dermatologicas Buenos Aires, Argentina
  • IMAI (Instituto Medico de Asistencia e Investigaciones) Buenos Aires, Argentina
  • LKH Feldkirch Abteilung fuer Dermatologie und Venerologie Feldkirch, Austria
View all 122 locations
View Trial Details
Completed

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE)

NCT01636687

Conditions
Disease Attributes, Pathologic Processes, Pathological Conditions, Anatomical, +11 more
Locations
  • Novartis Investigative Site Phoenix, Arizona, United States
  • Novartis Investigative Site Los Angeles, California, United States
  • Novartis Investigative Site Oceanside, California, United States
  • Novartis Investigative Site Overland Park, Kansas, United States
View all 39 locations
View Trial Details

Related conditions